Evidence map›Paper›PMID 42824449›Full record

ArticleHealth science reports2026

Incidence of Gynecological Cancers Is Rising in Northern Iran: A Population-Based, Serial Cross-Sectional Joinpoint Regression Study.

Mohammad Amouzadeh-Lichahi, Sahand Karimzadhagh, Nooshin Zaresharifi, Azadeh Jafari, Paridokht Karimian, Maryam Jafari, Gholamreza Sadeghi, Mohammad Ali Yazdanipour

Abstract read
In one paragraph

Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mohammad Amouzadeh-LichahiStudent Research Committee, School of Medicine, Anzali International Campus Guilan University of Medical Sciences Rasht Iran.ORCID https://orcid.org/0009-0006-8767-0446
Sahand KarimzadhaghDepartment of Internal Medicine, School of Medicine Shahid Beheshti University of Medical Sciences Tehran Iran.ORCID https://orcid.org/0009-0003-3583-278X
Nooshin ZaresharifiNeuroscience Research Center, School of Medicine Guilan University of Medical Sciences Rasht Iran.ORCID https://orcid.org/0000-0002-9925-4195
Azadeh JafariDepartment of Pathology, School of Medicine Guilan university of medical sciences Rasht Iran.ORCID https://orcid.org/0000-0002-4285-6486
Paridokht KarimianDepartment of Pathology, School of Medicine Guilan university of medical sciences Rasht Iran.ORCID https://orcid.org/0009-0006-5248-9372
Maryam JafariStudent Research Committee, School of Medicine, Anzali International Campus Guilan University of Medical Sciences Rasht Iran.ORCID https://orcid.org/0000-0003-4875-6133
Gholamreza SadeghiGuilan Cancer Registry Guilan University of Medical Sciences Rasht Iran.
Mohammad Ali YazdanipourNeuroscience Research Center Poursina Hospital Guilan University of Medical Sciences Rasht Iran.ORCID https://orcid.org/0000-0001-9084-0887

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aims: Gynecological cancers are a major global health burden, with ovarian, uterine, and cervical cancers being the most common types. Despite rising national incidence rates, recent comprehensive data for Gilan Province remain limited. This study investigated the incidence trends of gynecological cancers in Gilan Province, Northern Iran, from 2014 to 2018. Methods: A repeated cross-sectional analysis was conducted using data from the National Cancer Registry and Guilan University of Medical Sciences. Newly diagnosed cases of gynecological cancers were identified and classified according to ICD-O-3. Statistical analyses included descriptive statistics, one-way ANOVA for age group comparisons, and joinpoint regression to evaluate trends. Results: A total of 1058 cases were analyzed. The overall incidence rate rose by 98.2% over 5 years from 2014 to 2018, increasing from 10.72 to 21.25 cases per 100,000 individuals. The mean age of patients was 55.43 ± 3.63 years, showing no significant variation over time. Ovarian cancer was the most common type of gynecological cancer (42%), followed by corpus uteri (29.5%) and cervical cancer (15.2%), with 5-year incidence rates of 35.15, 24.7, and 12.73 cases per 100,000 individuals, respectively. Joinpoint regression suggested significant annual increases in both crude (APC = 19.19%, Conclusion: The incidence of gynecological cancers in Gilan province almost doubled during the study period, highlighting a substantial public health concern linked to long-term burden and mortality rates. Interventions should prioritize community-wide education, timely referrals, expanded access to diagnostic services, and enhanced awareness of early symptoms.

Indexed as

cancercorpus uterigynecological cancerovarytrend

Identifiers

PMID42824449
PMCPMC13628156

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.